Privacy Policy
Signals Blog

Contributors

Categories

Whenever something sounds too good to be true, it usually is. The expression is used widely in a variety of contexts, one of which is as a warning to avoid being taken in by a scam or taken advantage of. Unfortunately, it applies to the stem cell field too.

I am tempted to state that a new nano device, the Tissue Nanotransfection, developed to heal organs and repair injured tissue, blood vessels and nerve cells with the touch of a chip sounds too good to be true. But the research has been published in Nature Nanotechnology and comes from a team of researchers at Ohio State’s Center for Regenerative Medicine and Cell Based Therapies and Ohio State’s College of Engineering. While it sounds quite miraculous – “It takes just a fraction of a second. You simply touch the chip to the wounded area, then remove it. At that point, the cell reprogramming begins” (says lead researcher Dr. Chandan Sen, in Medical News Today) – it looks promising. Within one year, the scientists hope to move the device into human clinical trials.

Watch the video below to see the device in action and hear how it works.

Our regular feature, Right Turn, appears every Friday and we invite you to submit your own blog to info(at)ccrm.ca. We encourage you to be creative and use the right (!) side of your brain. We dare you to make us laugh! Right Turn features cartoons, photos, videos and other content to amuse, educate and encourage discussion.

As always, we welcome your feedback in the comment section.

The following two tabs change content below.
Avatar photo

Stacey Johnson

Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.